Explore our vetted product lines manufactured under rigorous non-GMO protocols, cGMP standard operating procedures, and strict lot-by-lot analytical release parameters.
Operating from our premier US plant in Springville, Utah, alongside integrated global facilities, PAG Pharmatech provides CDMO execution tailored for scale-focused supplement brands.
Our raw material management incorporates complete Identity Preservation (IP) tracking. From seed and harvest through extraction to blending, every botanical batch undergoes mandatory PCR (Polymerase Chain Reaction) gene testing to guarantee zero genetically engineered cross-contamination.
Eliminate multi-vendor friction. Our automated cleanroom suites support high-velocity production across Pectin/Gelatin Gummies, Compressed & Effervescent Tablets, Powder Stick Packs, HPMC Hard Capsules, Oil-Based Softgels, and Functional Pet Soft Chews under one roof.
Fully compliant with US 21 CFR Part 111 (Dietary Supplements) and Part 117 (Preventive Controls for Human Food). We deliver complete batch documentation including Certificates of Analysis (CoA), allergen containment matrices, and heavy metal testing.
Why leading global brands transition away from traditional toll manufacturers toward high-integrity Non-GMO CDMO partners.
| Evaluation Benchmark | Standard Contract Manufacturer | PAG Pharmatech Non-GMO CDMO Standard |
|---|---|---|
| Raw Material GMO Screening | Basic paper supplier declarations without lot validation. | ✓ Third-party DNA / PCR testing verified on every inbound raw batch. |
| Excipient & Carrier Verification | Frequent use of low-cost GMO corn maltodextrin or soy lecithin. | ✓ 100% Non-GMO Tapioca, Sunflower Lecithin, and Organic Rice Carriers. |
| Lead Time (Concept to Market) | 24 to 36 weeks due to fragmented supply chains. | ✓ Validated 90-Day Rapid Turn-Key Execution Framework. |
| Allergen & Cross-Contact Audit | Shared equipment lines with minimal physical segregation. | ✓ Positive-pressure cleanroom suites with automated CIP sanitation. |
| Marketplace Audit Readiness | Basic batch sheets; delays during Amazon/Retailer audits. | ✓ Turnkey documentation packages tailored for Amazon, Walmart & EU Entry. |
The global dietary supplement industry is undergoing a fundamental structural transformation. Consumer demand has evolved from basic nutritional supplementation to demanding strict ingredient transparency, sustainable sourcing, and absolute non-GMO verified supply chains. Procurement executives, brand owners, and quality directors are no longer treating Non-GMO verification as a simple marketing badge; it is now a foundational compliance imperative for brand equity and legal protection.
Genetically Modified Organisms (GMOs), primarily derived from bio-engineered crops such as corn, soy, canola, and sugar beets, frequently enter dietary supplements covertly through secondary carriers, excipients, and fermentation substrates. For example, common ingredients like ascorbic acid (Vitamin C), tocopherols (Vitamin E), citric acid, and maltodextrin are predominantly synthesized using GMO-derived corn or soy stocks. Partnering with a specialized top-tier Non-GMO supplement manufacturer ensures that every tier of the bill of materials (BOM) is audited down to the agricultural level.
Over 80% of accidental non-GMO compliance failures occur not within the primary active botanical extract, but through secondary processing aids such as flow agents (magnesium stearate derived from bio-engineered palm/soy oils), capsule shells, and flavor carriers. Top contract facilities maintain strict raw material approved supplier lists (ASL) to guarantee complete compliance.
As the market scales towards an estimated $230+ Billion global functional nutrition ecosystem by 2030, procurement professionals must align with contract factories capable of navigating upcoming regulatory and consumer headwinds:
Future-proof supplement manufacturers are moving past paper-based supplier self-declarations. Leading CDMOs utilize Quantitative Polymerase Chain Reaction (qPCR) assays to detect transgenic DNA fragments down to limits of detection (LOD) of less than 0.1%. Identity Preservation (IP) protocol guarantees that non-GMO crops maintain their genetic isolation from farm planting, extraction, solvent purification, and dry blending to final product bottling.
The market for traditional synthetic binders is shrinking rapidly. Modern non-GMO contract factories are replacing polyvinylpyrrolidone (PVP), silicon dioxide, and bio-engineered corn starch with natural functional alternatives:
With the rise of precision fermentation for producing novel amino acids, probiotics, and bioactive peptides, contract factories must strictly segregate bio-synthesized non-GMO strains from genetically engineered organisms. Transparency in microbial culture media (ensuring glucose substrates are non-GMO derived) represents the next frontier in supply chain auditing.
Headquartered in Springville, Utah, PAG Pharmatech America LLC operates as a fully integrated Contract Development and Manufacturing Organization (CDMO), eliminating traditional manufacturing bottlenecks through operational control, technical authority, and speed-to-market discipline.
Our US facility is purpose-built to deliver multi-dosage form agility under strict cGMP environments:
While traditional contract factories require 6 to 9 months for custom formulation launches, PAG Pharmatech's integrated R&D, raw material procurement, batch scaling, and stability testing compressed execution model delivers fully packaged, market-ready products in as few as 90 days.
When selecting a non-GMO supplement contract manufacturer, enterprise buyers should execute a structured multi-phase audit framework:
Step 1: Raw Material Vendor Qualification — Demand complete supply chain mapping for all active botanical extracts, minerals, and excipients. Verify that raw suppliers operate under validated Quality Assurance programs.
Step 2: Analytical Testing Protocol Review — Ensure the contract manufacturing facility maintains on-site HPLC, FTIR, and ICP-MS testing capabilities for identity, potency, heavy metals (Lead, Arsenic, Cadmium, Mercury), micro-pathogens, and PCR gene verification.
Step 3: Cleanroom Engineering & Changeover Audit — Inspect the facility's HVAC filtration systems, positive-air pressure controls, and automated Clean-in-Place (CIP) sanitation logs to prevent batch-to-batch cross-contamination.
Step 4: Retailer & Regulatory Compliance Documentation — Verify that finished product production records (BPR), Certificate of Analysis templates, and label claim verification dossiers comply directly with FDA 21 CFR Part 111 and major retail marketplace requirements (Amazon, Walmart, Target).
Essential insights for brand procurement leads, sourcing managers, and product development directors.
A authentic Non-GMO manufacturer maintains verified Identity Preservation (IP) systems, third-party facility audits (such as SQF, USDA Organic, or Non-GMO Project standards), and conducts lot-by-lot PCR (Polymerase Chain Reaction) DNA testing to verify zero bio-engineered genetic contamination across both active ingredients and secondary carrier excipients.
Our minimum order thresholds are structured to support both emerging market-leading DTC brands and commercial retail scaling: 6,000 units for custom gummies; 5,000 units for tablets, hard capsules, and softgels; 300 kg for blended powders and stick packs; and 2,000 units / 300 kg for pet nutritional soft chews.
Manufacturing takes place within isolated cleanroom suites equipped with independent HEPA air filtration and positive atmospheric pressure differential controls. Equipment undergoes multi-stage validated Cleaning-in-Place (CIP) procedures, validated with analytical swab testing prior to line clearance for subsequent production batches.
Yes. Our technical R&D team specializes in complete technology transfers and formula reverse-engineering. We analyze your existing bill of materials (BOM), match active botanical assay specifications, eliminate bio-engineered carriers or synthetic flow agents, and deliver equivalent or superior bio-available prototypes within 14 business days.
Every commercial production lot is released with a comprehensive compliance folder: complete Master Batch Production Records (BPR), batch-specific Certificate of Analysis (CoA) detailing potency, microbiological purity, heavy metals, and stability data, allergen declaration certificates, and full regulatory traceability documentation.
Yes, our flagship production plant located in Springville, Utah is FDA-registered and operates in full compliance with 21 CFR Part 111 (dietary supplement cGMP) and 21 CFR Part 117. We hold SQF Edition 9 certification, alongside Halal, Kosher, and USDA Organic processing compliance options.
